Target type: molecularfunction
Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium. [GOC:jl]
Calcium-dependent phospholipid binding is a molecular function that describes the ability of proteins to bind to phospholipids in a calcium-dependent manner. This binding is crucial for a wide range of cellular processes, including:
1. **Signal transduction:** Calcium-dependent phospholipid binding is essential for the activation of signaling pathways, such as the phosphoinositide signaling pathway. When calcium levels rise in the cell, it binds to specific phospholipids, triggering the recruitment of signaling proteins to the membrane and initiating downstream signaling events.
2. **Membrane trafficking:** Calcium-dependent phospholipid binding plays a role in regulating vesicle budding and fusion, essential processes for transporting molecules within the cell. It facilitates the assembly of protein complexes that control membrane curvature and the interaction between vesicles and target membranes.
3. **Cell adhesion:** Calcium-dependent phospholipid binding is involved in cell-cell adhesion, where it helps to mediate the interaction between cell surface proteins and phospholipids in the cell membrane. This binding can contribute to the formation of tight junctions and other cell-cell contacts.
4. **Cytoskeletal organization:** Calcium-dependent phospholipid binding influences the dynamics of the cytoskeleton, which provides structural support to the cell. It can regulate the assembly and disassembly of actin filaments, contributing to cell shape and movement.
5. **Enzyme activity:** Calcium-dependent phospholipid binding can modulate the activity of certain enzymes by providing a platform for their recruitment to the membrane or by altering their conformation.
The molecular mechanism of calcium-dependent phospholipid binding involves the interaction between positively charged calcium ions and negatively charged phosphate groups in the phospholipid headgroup. This interaction creates a favorable binding environment, allowing proteins with specific binding domains to interact with the phospholipid. These proteins often have EF-hand motifs or other calcium-binding domains, enabling them to sense and respond to changes in calcium levels.
Calcium-dependent phospholipid binding is a highly regulated process, with specific phospholipid binding proteins exhibiting selectivity for different types of phospholipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2). This selectivity contributes to the specificity of signaling pathways and other cellular processes.
In summary, calcium-dependent phospholipid binding is a fundamental molecular function that plays a critical role in a wide range of cellular processes by regulating signaling pathways, membrane trafficking, cell adhesion, cytoskeletal organization, and enzyme activity.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of cow. [OMA:A4IFJ5, PRO:DNx] | Bos taurus (cattle) |
Cytosolic phospholipase A2 gamma | A cytosolic phospholipase A2 gamma that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UP65] | Homo sapiens (human) |
Cytosolic phospholipase A2 | A cytosolic phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P47712] | Homo sapiens (human) |
Cytosolic phospholipase A2 beta | A cytosolic phospholipase A2 beta that is encoded in the genome of human. [PRO:DNx, UniProtKB:P0C869] | Homo sapiens (human) |
Annexin A2 | An annexin A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P07355] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
indomethacin | indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis. Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic; xenobiotic metabolite |
ici 204,219 | zafirlukast: a leukotriene D4 receptor antagonist | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
arachidonic acid | arachidonate : A long-chain fatty acid anion resulting from the removal of a proton from the carboxy group of arachidonic acid. icosa-5,8,11,14-tetraenoic acid : Any icosatetraenoic acid with the double bonds at positions 5, 8, 11 and 14. | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
N-(3,4-dimethylphenyl)-2-[[5-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]thio]acetamide | anilide | ||
arachidonyltrifluoromethane | AACOCF3 : A fatty acid derivative that is arachidonic acid in which the OH part of the carboxy group has been replaced by a trifluoromethyl group arachidonyltrifluoromethane: structure given in first source; inhibits 85-kDa phospholipase A2 | fatty acid derivative; ketone; olefinic compound; organofluorine compound | EC 3.1.1.4 (phospholipase A2) inhibitor |
amentoflavone | biflavonoid; hydroxyflavone; ring assembly | angiogenesis inhibitor; antiviral agent; cathepsin B inhibitor; P450 inhibitor; plant metabolite | |
ochnaflavone | ochnaflavone : A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. ochnaflavone: from Lonicera japonica; structure given in first source | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
efipladib | efipladib: structure in first source | ||
methyl arachidonylfluorophosphonate | phosphonic ester | ||
pyrrophenone | pyrrophenone: structure in first source |